9 Janttary 2019

Drues used in Diabetes (A10)

. Insulins and Analosues (A10A)

1. Insulin (human
a.B phas c insulin
b. Biphasic Isophane
Human lnsulin
c. Human Regular Solution for Injection
Insulin (1.M./S.C./1.V.); Solution
d. lnsulin human + 100l.U.iml for Injection (S.C./I.V.);
Isophane Insulin Solution for Injection
Human (S.C.); Suspension for
e, Neutral insulin Human Injection (S.C.)
* lsophane Insulin
Human
f. Recombinant Human
Insulin
2. Insulin aspart
a. lnsulin aspafi
b. Biphasic Insulin
Aspart
c, Biphasic Insulin 100 Units/ml Solution for Injection (S.C.)
Aspart 30
d. Biphasic Insulin
Aspart 50
3. Insulin degludec 100 Units/ml Solution for Injection (S.C.)
4. Insulin degludec and Insulin 100 Units/mL (70% lnsulin
aspafi Degludec/30% lnsulin Solution for Injection (S.C.)
Aspart)
5. Insulin degludec and
100 Units/3.6 mg per mL
Liraglutide Solution for Injection (S.C.)
6. Insulin detemir 100Units/ml Solution for Injection (S.C.)
7. lnsuiin glargine 100Units/ml
Solution for Injection (S.C.)
300 Units/ml
E. lnsulin glargine and 3.64 mg (equivalent to 100
Lixisenatide Units of Insulin glarginel
33 mcg per mL Solution)
Solution for Iniection (S.C.)
3.6-i nrg (equrralent Lo 100
Units of Insulin glargine/
50 mcg per mL Soiution')
9. Insulin glulisine 3.49 mgl mL (equivalent Solution for Injection (S.C.)
to 100 units / mL) Solution for Iniection
 (S ubcutaneous/Continuous
S.C. Pump
Infusion/Intravenous)
10. Insulin lispro
Solution for Injection
a. rDNA origin (r.v./s.c./r.M.)
b. 50% Insulin Lispro
and 50Yo Insulin-
Lispro-Protamine
100 Units/ml (3.5 mg/ml)
Sulfate Suspension for Injection
c. 25% Insulin Lispro (s.c.)
and 75ok Insulin-
Lispro-Protamine
Sulfate

Blood Glucose Lowering Druss. excludins Insulins (A10B)

A. Biguanides (A10BA)
Metformin Tablet
Film-Coated Tablet
500 mg Extended-Release Tablet
Sustained-Release Capsule
Oral Solution
750 me Extended-Release Tablet
Tablet
Film-Coated Tablet
850 mg
Extended-Rel ease Tablet
Oral Solution
Tablet
Film-Coated Tablet
1000 mg Extended-Rel ease Tablet
Sustained-Release Capsule
Oral Solution
ullbnylureas (A10BB
1. Glibenclamide 5mg Tablet
2. Glipizide Tablet
2.5 mg
Extended-Reiease Tablet
Tablet
J lng Extended-Rel ease Tablet
Control led-Rel ease Tabl et
Extended-Rel ease Tablet
10 mg
Control lcd-Rolease Tab let
3. Gliclazide Modifi ed-Release Tablet
30 mg
Prolonged-Release Tablet
60 ms Modifi ed-Release Tablet
 Fi L:Cil ir j.s Mi.i J. L1 i V i Si i Ll i'\l

Tablet
80 mg
Mod ifi ed-Release Tablet
4. Glimepiride 1ms
2ms
Tablet; Film-Coated Tablet
3mg
4mg
C. Combinations of oral blood glucose lowering drugs (A10BD)
1. Metformin and
Sulfonylureas
a. Metformin and
500mg+5mg Tablet
Glipizide
b. Metformin and 500 ms + 80 ms Film-Coated Tablet
Gliclazide 850 mg + 80 mg
c. Metformin and 500me+1ms Tablet
Glimepiride Tablet
Fiim-Coated Tablet
500mg+2mg Sustained-Release Capsule
Extended-Release Tablet
Prolonged-Release Tablet
1s+2ms Tablet
d. Metformin and 250 ms. + 1.25 ms
Glibenclamide 500 mg + 2.5 mg Film-Coated Tablet
500me+5ms
500 me + 5ms
Tablet
I s+5mu
2. Metformin and Pioglitazone 500 me + 15 ms
Film-Coated Tablet
850 me +15 me
3. Glimepiride and Pioglitazone 15 mel2 ms.
Tablet
30 ms,l2 mg
4. Metfonnin and Sitagliptin Tablet
50 mg + 500 mg
Film-Coated Tablet
50 mg + 850 me Tablet
50 me + 1000 me Tablet
50me+1e Film-Coated Tablet
100 mg + I g Extended-Rel ease Tab I et
5. Metformin and Vildagliptin 50 rng + 500 me
50 me + 850 me Film-Coated Tablet
50 mg + 1000 me
6, Pioglitazone and Alogliptin 12.5 ms,l15 ms,
12.5 mel30 me
Film-Coated Tablet
2i mgi l5 m
25 mg/30 mg
7. Metformin and Saxagliptin 2.5 ms.l1 s
Film-Coated Tablet
5 ms/500 me
 iiIr],-r i; l;s "i"
i.,nG t i v i s i ai hl

5 meil s
8. Metformin and Linagliptin 2.5 mg + 500 ms
2.5 ms, + 850 me Film-Coated Tablet
2.5 ms, + 1000 me
9. Metformin and Dapagliflozin 5 me/500 me
5 mg/l000 me
Tabiet
l0 me/500 ms
10 me/1000 me
10. Linagiiptin and 10 me/5 me
Empagliflozin Film-Coated Tablet
25 mel5 mg
l. Metformin and 5 me/500 me
Empagliflozin 5 mg/850 ms
5 ms,ll 0
Film-Coated Tablet
12.5 me/500 mg
12.5 mg/850 mg
12.5 mell s
12. Pio glitazone, Metformin and 15 mei500 mgi 1 me
Glimepiride** Film-Coated Tablet
15 me/500 ms.l?ms.
13. Saxagliptin and
5 mg/10 mg Film-Coated Tablet
Dapaeiiflozin
D. Alpha glucosidase inhitritors (A10BF)
Tabiet
50 mg
l Acarbose Film-Coated Tablet
100 me Tablet
Tabiet
200 mcg
2. Voglibose Orally Disintegrating Tablet
Tablet
300 mcg
Dispersible Tablet
E. Thiazolidinediones (A10BG)
Tablet
15 mg
1. Pioglitazone Film-Coated Tablet
30 mg Tablet
45 mg Tablet
F. Dipeptidyl peptidase 4 (DPP-4) inhibitors (A10BH)
1. Sitagliptin 25 mg
50 ms Film-Coated Tablet
100 mg
2, Vildagliptin 50 mg Tablet
3. Saxagliptin ?.5 me Film-Coated Tablet
5mg
4. Linagliptin 5mg Tablet
5. Gemigliptin 50 mg Film-Coated Tablet
6. Sitagiiptin and Simvastatin 100 me + 10 ms
Film-Coated Tablet
100 me + 20 ms
G. Glucagon-like peptide-l (GLP-I) analogues (A10BO
Powder for Suspension for
2mg
Iniection (S.C.)
1. Exenatide 250 mcgiml (5 mcgidose)
Solution for Injection (S.C.)
250 mcgiml (10
mcgidose)
2, Liraglutide 6 mglmL Solution for iniection (S.C.)
10 mcg + 0.2 mL
(0.15 mgi3 mL)
3. Lixisenatide Solution loi lnjection (S.C.)
20 mcg + 0.2 mL

H. Sodium-glucose co-transporter 2 (SGLT2) inhibitors (AlOBK)

1. Dapagliflozin 5mg
10 mg
Tablet
100 mg
2. Canagliflozin Film-Coated Tabiet
300 me
10 mg
3, Empagiiflozin Film-Coated Tablet
25 mg
I. Other blood glucose lowering drugs, excluding insulins
500 mcg
1. Repaglinide 1mg Tablet
2mg
2. Nateglinide 120 mg Fiim-Coated Tablet